| Application number | Title of the application | Filing Date | Status |
|---|
| 09/647041 | PEPTIDE LIGANDS FOR THE HUMAN FIBROBLAST GROWTH FACTOR (FGF) RECEPTOR | Sep 24, 2000 | Abandoned |
Array
(
[id] => 990685
[patent_doc_number] => 06919211
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-07-19
[patent_title] => 'Polypeptide arrays'
[patent_app_type] => utility
[patent_app_number] => 09/653761
[patent_app_country] => US
[patent_app_date] => 2000-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 58
[patent_no_of_words] => 57774
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09653761
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/653761 | Polypeptide arrays | Aug 31, 2000 | Issued |
| 09/652178 | Diazabicyclononane scaffold for combinatorial synthesis | Aug 30, 2000 | Abandoned |
Array
(
[id] => 1028108
[patent_doc_number] => 06881825
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-19
[patent_title] => 'Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues'
[patent_app_type] => utility
[patent_app_number] => 09/653182
[patent_app_country] => US
[patent_app_date] => 2000-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 68
[patent_no_of_words] => 20346
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/881/06881825.pdf
[firstpage_image] =>[orig_patent_app_number] => 09653182
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/653182 | Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues | Aug 30, 2000 | Issued |
Array
(
[id] => 1220232
[patent_doc_number] => 06703199
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-09
[patent_title] => 'Artificial antibody polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/637614
[patent_app_country] => US
[patent_app_date] => 2000-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 29
[patent_no_of_words] => 26063
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/703/06703199.pdf
[firstpage_image] =>[orig_patent_app_number] => 09637614
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/637614 | Artificial antibody polypeptides | Aug 10, 2000 | Issued |
| 09/629596 | Phase display of a biologically active bacillus thuringiensis toxin | Jul 30, 2000 | Abandoned |
| 09/530431 | Method for mapping the active sites bound by enzymes that covalently modify substrate molecules | Jul 25, 2000 | Abandoned |
Array
(
[id] => 1012546
[patent_doc_number] => 06897017
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-24
[patent_title] => 'Vivo library-versus-library selection of optimized protein-protein interactions'
[patent_app_type] => utility
[patent_app_number] => 09/603885
[patent_app_country] => US
[patent_app_date] => 2000-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7939
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/897/06897017.pdf
[firstpage_image] =>[orig_patent_app_number] => 09603885
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/603885 | Vivo library-versus-library selection of optimized protein-protein interactions | Jun 25, 2000 | Issued |
Array
(
[id] => 1261122
[patent_doc_number] => 06664067
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'Instrument for high throughput measurement of material physical properties and method of using same'
[patent_app_type] => B1
[patent_app_number] => 09/580024
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 25
[patent_no_of_words] => 15744
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664067.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580024
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580024 | Instrument for high throughput measurement of material physical properties and method of using same | May 25, 2000 | Issued |
| 09/508311 | FUROPYRROLIDINE DERIVATIVES AND THEIR USE AS SERINE PROTEASE INHIBITORS | May 25, 2000 | Abandoned |
Array
(
[id] => 4320357
[patent_doc_number] => 06328970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Rapamycin position 27 conjugates'
[patent_app_type] => 1
[patent_app_number] => 9/576952
[patent_app_country] => US
[patent_app_date] => 2000-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11934
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/328/06328970.pdf
[firstpage_image] =>[orig_patent_app_number] => 576952
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/576952 | Rapamycin position 27 conjugates | May 23, 2000 | Issued |
| 09/575345 | Construction of incremental truncation libraries | May 18, 2000 | Abandoned |
Array
(
[id] => 1376871
[patent_doc_number] => 06555313
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Production of anti-self antibodies from antibody segment repertoires and displayed on phage'
[patent_app_type] => B1
[patent_app_number] => 09/572392
[patent_app_country] => US
[patent_app_date] => 2000-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 23510
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555313.pdf
[firstpage_image] =>[orig_patent_app_number] => 09572392
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/572392 | Production of anti-self antibodies from antibody segment repertoires and displayed on phage | May 15, 2000 | Issued |
Array
(
[id] => 1241065
[patent_doc_number] => 06682888
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Genes expressed in alzheimer\'s disease'
[patent_app_type] => B1
[patent_app_number] => 09/566921
[patent_app_country] => US
[patent_app_date] => 2000-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 68729
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/682/06682888.pdf
[firstpage_image] =>[orig_patent_app_number] => 09566921
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/566921 | Genes expressed in alzheimer's disease | May 4, 2000 | Issued |
Array
(
[id] => 1107269
[patent_doc_number] => 06808876
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-26
[patent_title] => 'Cellular regulators of infectious agents and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/563794
[patent_app_country] => US
[patent_app_date] => 2000-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 23181
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/808/06808876.pdf
[firstpage_image] =>[orig_patent_app_number] => 09563794
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/563794 | Cellular regulators of infectious agents and methods of use | May 1, 2000 | Issued |
Array
(
[id] => 1594018
[patent_doc_number] => 06491923
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Stabilized conjugates of uncomplexed subunits of multimeric proteins'
[patent_app_type] => B1
[patent_app_number] => 09/565286
[patent_app_country] => US
[patent_app_date] => 2000-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 7823
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/491/06491923.pdf
[firstpage_image] =>[orig_patent_app_number] => 09565286
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/565286 | Stabilized conjugates of uncomplexed subunits of multimeric proteins | May 1, 2000 | Issued |
Array
(
[id] => 1419437
[patent_doc_number] => 06509454
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-21
[patent_title] => 'Free solution ligand interaction molecular separation method'
[patent_app_type] => B1
[patent_app_number] => 09/561734
[patent_app_country] => US
[patent_app_date] => 2000-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8160
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/509/06509454.pdf
[firstpage_image] =>[orig_patent_app_number] => 09561734
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/561734 | Free solution ligand interaction molecular separation method | Apr 26, 2000 | Issued |
| 09/558712 | Method for producing genomic libraries and genomic libraries produced therewith | Apr 25, 2000 | Abandoned |
Array
(
[id] => 735213
[patent_doc_number] => RE039071
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-04-18
[patent_title] => 'Anhydro-and isomer-a-21978c cyclic peptides'
[patent_app_type] => reissue
[patent_app_number] => 09/547357
[patent_app_country] => US
[patent_app_date] => 2000-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4714
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039071.pdf
[firstpage_image] =>[orig_patent_app_number] => 09547357
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/547357 | Anhydro-and isomer-a-21978c cyclic peptides | Apr 10, 2000 | Issued |
| 09/538038 | Insulin and IGF-1 receptor agonists and antagonists | Mar 28, 2000 | Abandoned |
